{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:23Z","timestamp":1787003783830,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Respiratory infections, including pneumonia and COVID-19, are major causes of global mortality and morbidity. Recent advancements in organ-on-a-chip (OOC) technologies have paved the way for human-based disease models, offering new tools for studying disease mechanisms and accelerating drug development. The aim of this study was to establish a lung-liver fluidic system to study the interaction of both organ modules during infection. A two organ (lung-liver) fluidic system was established using primary human bronchial (HBECs) or alveolar type epithelial cells (AT) for the lung module and Huh-7 cells for the liver module. Inactivated non-typeable\n                    <jats:italic>Haemophilus influenzae<\/jats:italic>\n                    (NTHi) and\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    PAO1 (PAO1) were applied to the lung module\n                    <jats:italic>.<\/jats:italic>\n                    Secreted mediators were screened by dot-blot analysis and quantified. The impact of bacteria-exposed epithelial cells on the liver cell transcriptome was analyzed via mRNA sequencing. Lung and liver cells established stable cultures in a circulatory fluidic system. Activation of HBECs or ATCs with NTHi or PAO1 resulted in the secretion of multiple inflammatory mediators into the microfluidic medium including tumor necrosis factor-alpha (TNF-\u03b1), monocyte chemotactic protein-1 (MCP-1) and macrophage inflammatory protein-1-\u03b1 (MIP-1\u03b1). Addition of lung cells and application of bacterial onto the HBEC module led to significant transcriptomic alterations in the liver cell module. Gene ontology enrichment analysis showed the induction of various pathways involved in host defense, metabolism, repair, and acute phase response. In conclusion, a two-organ lung-liver fluidic system was established to study the interaction of the organ modules during infection. Mediators like cytokines are released from epithelial culture modules into the fluidic circulation after exposure to bacterial pathogens that significantly modify the gene expression patterns of liver cells.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-22682-z","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:50:10Z","timestamp":1760014210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Modeling of lung-liver interaction during infection in a human fluidic organ-on-a-chip"],"prefix":"10.1038","volume":"15","author":[{"given":"Susanne","family":"Reinhold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Pourrostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ritzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortense","family":"Slevogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Beisswenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"22682_CR1","first-page":"17","volume":"7","author":"D Konar","year":"2016","unstructured":"Konar, D., Devarasetty, M., Yildiz, D. V., Atala, A. & Murphy, S. V. Lung-on-a-chip technologies for disease modeling and drug development. Biomed. Eng. Comput. Biol. 7, 17\u201327 (2016).","journal-title":"Biomed. Eng. Comput. Biol."},{"key":"22682_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.biotechadv.2016.02.006","volume":"34","author":"A Doryab","year":"2016","unstructured":"Doryab, A., Amoabediny, G. & Salehi-Najafabadi, A. Advances in pulmonary therapy and drug development: Lung tissue engineering to lung-on-a-chip. Biotechnol. Adv. 34, 588\u2013596 (2016).","journal-title":"Biotechnol. Adv."},{"key":"22682_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cell.2016.02.049","volume":"164","author":"DE Ingber","year":"2016","unstructured":"Ingber, D. E. Reverse engineering human pathophysiology with organs-on-chips. Cell 164, 1105\u20131109 (2016).","journal-title":"Cell"},{"key":"22682_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","volume":"20","author":"LA Low","year":"2021","unstructured":"Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P. & Tagle, D. A. Organs-on-chips: into the next decade. Nat. Rev. Drug Discov. 20, 345\u2013361 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"22682_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4046\/trd.2017.80.1.1","volume":"80","author":"DK Oh","year":"2017","unstructured":"Oh, D. K., Kim, Y. S. & Oh, Y. M. Lung regeneration therapy for chronic obstructive pulmonary disease. Tuberc. Respir. Dis. (Seoul) 80, 1\u201310 (2017).","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"issue":"472\u2013488","key":"22682_CR6","volume":"21","author":"A Jacob","year":"2017","unstructured":"Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21(472\u2013488), e410 (2017).","journal-title":"Cell Stem Cell"},{"issue":"Suppl 1","key":"22682_CR7","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1513\/AnnalsATS.201410-442MG","volume":"12","author":"DD Huh","year":"2015","unstructured":"Huh, D. D. A human breathing lung-on-a-chip. Ann. Am. Thorac. Soc. 12(Suppl 1), S42-44 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"22682_CR8","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/s41467-022-29562-4","volume":"13","author":"H Bai","year":"2022","unstructured":"Bai, H. et al. Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip. Nat. Commun. 13, 1928 (2022).","journal-title":"Nat. Commun."},{"key":"22682_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41551-021-00718-9","volume":"5","author":"L Si","year":"2021","unstructured":"Si, L. et al. A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat. Biomed. Eng. 5, 815\u2013829 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"22682_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nmeth.3697","volume":"13","author":"KH Benam","year":"2016","unstructured":"Benam, K. H. et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat. Methods 13, 151\u2013157 (2016).","journal-title":"Nat. Methods"},{"key":"22682_CR11","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1039\/c3lc50234a","volume":"13","author":"I Wagner","year":"2013","unstructured":"Wagner, I. et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 13, 3538\u20133547 (2013).","journal-title":"Lab Chip"},{"key":"22682_CR12","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1039\/C8LC01029C","volume":"18","author":"D Bovard","year":"2018","unstructured":"Bovard, D. et al. A lung\/liver-on-a-chip platform for acute and chronic toxicity studies. Lab Chip 18, 3814\u20133829 (2018).","journal-title":"Lab Chip"},{"key":"22682_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/aivt.2018.0009","volume":"4","author":"S Buesch","year":"2018","unstructured":"Buesch, S., Schroeder, J., Bunger, M., D\u2019Souza, T. & Stosik, M. A novel in vitro liver cell culture flow system allowing long-term metabolism and hepatotoxicity studies. Appl. Vitro Toxicol. 4, 232\u2013237 (2018).","journal-title":"Appl. Vitro Toxicol."},{"key":"22682_CR14","doi-asserted-by":"publisher","first-page":"1359451","DOI":"10.3389\/fcell.2024.1359451","volume":"12","author":"JI Kennedy","year":"2024","unstructured":"Kennedy, J. I. et al. Organ-on-a-chip for studying immune cell adhesion to liver sinusoidal endothelial cells: the potential for testing immunotherapies and cell therapy trafficking. Front. Cell Dev. Biol. 12, 1359451 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"22682_CR15","first-page":"e52526","volume":"98","author":"EM Materne","year":"2015","unstructured":"Materne, E. M. et al. The multi-organ chip\u2013a microfluidic platform for long-term multi-tissue coculture. J. Vis. Exp. 98, e52526 (2015).","journal-title":"J. Vis. Exp."},{"key":"22682_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpb.2015.03.002","volume":"95","author":"I Maschmeyer","year":"2015","unstructured":"Maschmeyer, I. et al. Chip-based human liver-intestine and liver-skin co-cultures\u2014a first step toward systemic repeated dose substance testing in vitro. Eur. J. Pharm. Biopharm. 95, 77\u201387 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"22682_CR17","doi-asserted-by":"publisher","first-page":"20030","DOI":"10.1038\/srep20030","volume":"6","author":"C Oleaga","year":"2016","unstructured":"Oleaga, C. et al. Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci. Rep. 6, 20030 (2016).","journal-title":"Sci. Rep."},{"key":"22682_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1039\/C4LC01252F","volume":"15","author":"AO Stucki","year":"2015","unstructured":"Stucki, A. O. et al. A lung-on-a-chip array with an integrated bio-inspired respiration mechanism. Lab Chip 15, 1302\u20131310 (2015).","journal-title":"Lab Chip"},{"key":"22682_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s42242-021-00136-5","volume":"4","author":"AM Sun","year":"2021","unstructured":"Sun, A. M., Hoffman, T., Luu, B. Q., Ashammakhi, N. & Li, S. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: A review. Biodes. Manuf. 4, 757\u2013775 (2021).","journal-title":"Biodes. Manuf."},{"key":"22682_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/v13050792","volume":"13","author":"N Heinen","year":"2021","unstructured":"Heinen, N., Klohn, M., Steinmann, E. & Pfaender, S. In vitro lung models and their application to study SARS-CoV-2 pathogenesis and disease. Viruses 13, 792 (2021).","journal-title":"Viruses"},{"key":"22682_CR21","doi-asserted-by":"publisher","first-page":"025012","DOI":"10.1088\/1758-5090\/ab7073","volume":"12","author":"S Deinhardt-Emmer","year":"2020","unstructured":"Deinhardt-Emmer, S. et al. Co-infection with Staphylococcus aureus after primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-a-chip model. Biofabrication 12, 025012 (2020).","journal-title":"Biofabrication"},{"key":"22682_CR22","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1021\/acs.accounts.1c00411","volume":"54","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Wang, P. & Qin, J. Microfluidic organs-on-a-chip for modeling human infectious diseases. Acc. Chem. Res. 54, 3550\u20133562 (2021).","journal-title":"Acc. Chem. Res."},{"key":"22682_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/mi12050470","volume":"12","author":"M Rothbauer","year":"2021","unstructured":"Rothbauer, M. et al. A decade of organs-on-a-chip emulating human physiology at the microscale: A critical status report on progress in toxicology and pharmacology. Micromachines (Basel) 12, 470 (2021).","journal-title":"Micromachines (Basel)"},{"key":"22682_CR24","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/s41598-021-96565-4","volume":"11","author":"T Bluhmki","year":"2021","unstructured":"Bluhmki, T. et al. Functional human iPSC-derived alveolar-like cells cultured in a miniaturized 96-Transwell air-liquid interface model. Sci. Rep. 11, 17028 (2021).","journal-title":"Sci. Rep."},{"key":"22682_CR25","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1038\/s41598-020-62226-1","volume":"10","author":"S van Riet","year":"2020","unstructured":"van Riet, S. et al. In vitro modelling of alveolar repair at the air-liquid interface using alveolar epithelial cells derived from human induced pluripotent stem cells. Sci. Rep. 10, 5499 (2020).","journal-title":"Sci. Rep."},{"key":"22682_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ejim.2004.06.011","volume":"15","author":"MF Jinks","year":"2004","unstructured":"Jinks, M. F. & Kelly, C. A. The pattern and significance of abnormal liver function tests in community-acquired pneumonia. Eur. J. Intern. Med. 15, 436\u2013440 (2004).","journal-title":"Eur. J. Intern. Med."},{"key":"22682_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40635-020-00337-9","volume":"8","author":"R Herrero","year":"2020","unstructured":"Herrero, R. et al. Liver-lung interactions in acute respiratory distress syndrome. Intensive Care Med. Exp. 8, 48 (2020).","journal-title":"Intensive Care Med. Exp."},{"key":"22682_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1124\/mol.112.082305","volume":"83","author":"L Sivertsson","year":"2013","unstructured":"Sivertsson, L., Edebert, I., Palmertz, M. P., Ingelman-Sundberg, M. & Neve, E. P. A. Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation. Mol. Pharmacol. 83, 659\u2013670 (2013).","journal-title":"Mol. Pharmacol."},{"key":"22682_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/pharmaceutics9010003","volume":"9","author":"E Jouan","year":"2016","unstructured":"Jouan, E., Le V\u00e9e, M., Denizot, C., Parmentier, Y. & Fardel, O. Drug transporter expression and activity in human hepatoma HuH-7 cells. Pharmaceutics 9, 3 (2016).","journal-title":"Pharmaceutics"},{"key":"22682_CR30","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1038\/s41598-020-60689-w","volume":"10","author":"B Elbakary","year":"2020","unstructured":"Elbakary, B. & Badhan, R. K. S. A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation. Sci. Rep. 10, 3788 (2020).","journal-title":"Sci. Rep."},{"key":"22682_CR31","doi-asserted-by":"publisher","first-page":"11644","DOI":"10.1038\/s41598-017-11271-4","volume":"7","author":"P Chandorkar","year":"2017","unstructured":"Chandorkar, P. et al. Fast-track development of an in vitro 3D lung\/immune cell model to study Aspergillus infections. Sci. Rep. 7, 11644 (2017).","journal-title":"Sci. Rep."},{"key":"22682_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1164\/rccm.201507-1414OC","volume":"194","author":"CR Butler","year":"2016","unstructured":"Butler, C. R. et al. Rapid expansion of human epithelial stem cells suitable for airway tissue engineering. Am. J. Respir. Crit. Care Med. 194, 156\u2013168 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"22682_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s10020-024-00990-w","volume":"30","author":"Y Yao","year":"2024","unstructured":"Yao, Y. et al. Co-culture of human AT2 cells with fibroblasts reveals a MUC5B phenotype: insights from an organoid model. Mol. Med. 30, 227 (2024).","journal-title":"Mol. Med."},{"key":"22682_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-023-02636-7","volume":"25","author":"M Brand","year":"2024","unstructured":"Brand, M. et al. Biochemical and transcriptomic evaluation of a 3D lung organoid platform for pre-clinical testing of active substances targeting senescence. Respir. Res. 25, 3 (2024).","journal-title":"Respir. Res."},{"key":"22682_CR35","doi-asserted-by":"publisher","first-page":"20190045","DOI":"10.1098\/rsfs.2019.0045","volume":"10","author":"L Hyndman","year":"2020","unstructured":"Hyndman, L. et al. Mathematical modelling of fluid flow and solute transport to define operating parameters for perfusion cell culture systems. Interface Focus 10, 20190045 (2020).","journal-title":"Interface Focus"},{"key":"22682_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"22682_CR37","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"22682_CR38","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41551-023-01054-w","volume":"8","author":"P Wang","year":"2024","unstructured":"Wang, P. et al. Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system. Nat. Biomed. Eng. 8, 1053\u20131068 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"22682_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s13238-020-00811-w","volume":"12","author":"R Pei","year":"2021","unstructured":"Pei, R. et al. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection. Protein Cell 12, 717\u2013733 (2021).","journal-title":"Protein Cell"},{"key":"22682_CR40","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.4049\/jimmunol.178.5.3134","volume":"178","author":"AK Mayer","year":"2007","unstructured":"Mayer, A. K. et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J. Immunol. 178, 3134\u20133142 (2007).","journal-title":"J. Immunol."},{"key":"22682_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.15252\/emmm.201708213","volume":"10","author":"RE Hynds","year":"2018","unstructured":"Hynds, R. E., Bonfanti, P. & Janes, S. M. Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond. EMBO Mol. Med. 10, 139\u2013150 (2018).","journal-title":"EMBO Mol. Med."},{"key":"22682_CR42","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1021\/acsbiomaterials.1c01463","volume":"8","author":"D Baptista","year":"2022","unstructured":"Baptista, D. et al. 3D Lung-on-chip model based on biomimetically microcurved culture membranes. ACS Biomater. Sci. Eng. 8, 2684\u20132699 (2022).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"22682_CR43","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.3390\/ijms24043232","volume":"24","author":"UMN Cao","year":"2023","unstructured":"Cao, U. M. N. et al. Microfluidic organ-on-a-chip: A guide to biomaterial choice and fabrication. Int. J. Mol. Sci. 24, 3232 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"22682_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.taap.2007.03.032","volume":"222","author":"KM Olsavsky","year":"2007","unstructured":"Olsavsky, K. M. et al. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol. Appl. Pharmacol. 222, 42\u201356 (2007).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"22682_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1124\/dmd.110.035873","volume":"39","author":"L Guo","year":"2011","unstructured":"Guo, L. et al. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab. Dispos. 39, 528\u2013538 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"22682_CR46","doi-asserted-by":"publisher","first-page":"14333","DOI":"10.1038\/s41598-022-18174-z","volume":"12","author":"C Saran","year":"2022","unstructured":"Saran, C. et al. A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity. Sci. Rep. 12, 14333 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22682-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:04:47Z","timestamp":1760018687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22682-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22682"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22682-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35241"}}